Germany’s enmodes won recognition at the recent 2017 Design of Medical Devices Conference in Minneapolis for its RAS-Q technology to help people with pulmonary hypertension (PH). RAS-Q is a respiratory assist device that offers comprehensive, fully portable, cost-effective and protective treatment for PH patients. One week before the April 9-12 conference where RAS-Q won an Emerging Medical Innovation Valuation Competition award, enmodes presented in vivo resultsRead more about RAS-Q Lung Support Device for PH Patients Wins Emerging Medical Innovation Award[…]
Read more RAS-Q Lung Support Device for PH Patients Wins Emerging Medical Innovation Award
Background
Chronic obstructive pulmonary disease (COPD) is the 4th common cause of death whereby most of the cases are related to pulmonary hypertension (PH) and consecutive right heat failure.
In Germany, 236,644 hospitalizations due to PH were reported in 2014, with similar numbers in the other European countries. In the US, 728,983 hospitalizations and 21,292 deaths were reported in 2010, with an annual growth rate of ~10%. There is currently no cure available. Medication attenuates and prolongs the disease but is very costly at ~10.000 €/months.
No system is available to support these patients, because state-of-the-art technology is non-physiological, has high pressure loss and a high risk for thrombosis.